Cargando…

SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines

Detalles Bibliográficos
Autores principales: Thiruvengadam, Ramachandran, Binayke, Akshay, Awasthi, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610239/
https://www.ncbi.nlm.nih.gov/pubmed/34826382
http://dx.doi.org/10.1016/S1473-3099(21)00697-6
_version_ 1784603069294575616
author Thiruvengadam, Ramachandran
Binayke, Akshay
Awasthi, Amit
author_facet Thiruvengadam, Ramachandran
Binayke, Akshay
Awasthi, Amit
author_sort Thiruvengadam, Ramachandran
collection PubMed
description
format Online
Article
Text
id pubmed-8610239
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-86102392021-11-24 SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines Thiruvengadam, Ramachandran Binayke, Akshay Awasthi, Amit Lancet Infect Dis Comment Elsevier Ltd. 2022-03 2021-11-23 /pmc/articles/PMC8610239/ /pubmed/34826382 http://dx.doi.org/10.1016/S1473-3099(21)00697-6 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
Thiruvengadam, Ramachandran
Binayke, Akshay
Awasthi, Amit
SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
title SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
title_full SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
title_fullStr SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
title_full_unstemmed SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
title_short SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
title_sort sars-cov-2 delta variant: a persistent threat to the effectiveness of vaccines
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610239/
https://www.ncbi.nlm.nih.gov/pubmed/34826382
http://dx.doi.org/10.1016/S1473-3099(21)00697-6
work_keys_str_mv AT thiruvengadamramachandran sarscov2deltavariantapersistentthreattotheeffectivenessofvaccines
AT binaykeakshay sarscov2deltavariantapersistentthreattotheeffectivenessofvaccines
AT awasthiamit sarscov2deltavariantapersistentthreattotheeffectivenessofvaccines